Intelligence · Clinical pipeline
Neurology & CNS · Phase I
Neurology & CNS programs at Phase I — ClinicalTrials.gov pipeline intelligence.
Programs 11
Quick answer
Neurology & CNS Phase I programs: NovaPharmaNews indexes 11 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Anaxis Pharma 10 programs
- Takeda 10 programs
- BRIGHT MINDS BIOSCIENCES 9 programs
- NEUROCRINE BIOSCIENCES 7 programs
- HOFFMANN-LA ROCHE 6 programs
- Chinese Academy of 5 programs
- Alnylam Netherlands 4 programs
- Denali Therapeutics 4 programs
- IONIS PHARMACEUTICALS 4 programs
- Ultragenyx UK 4 programs
- United Therapeutics Europe 4 programs
- SUPERNUS PHARMACEUTICALS 3 programs
Pipeline programs
-
BXCL501 80 Micrograms
BioXcel Therapeutics
Schizophrenia
1 trial -
Dronabinol
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
LY03010/CT-EUR-102
Lacuna Pharma Pty Ltd
Schizophrenia
1 trial -
Motivational Interviewing
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Risperidone
The First People's Hospital of Lianyungang
Schizophrenia
1 trial -
Roflumilast
Takeda
Schizophrenia
1 trial -
SPD489 (Lisdexamfetamine dimesylate)
Takeda
Schizophrenia
1 trial -
TAK-058
Takeda
Schizophrenia
1 trial -
TAK-063
Takeda
Schizophrenia
1 trial -
TV44749-BA-10196
Lacuna Pharma Pty Ltd
Schizophrenia
1 trial -
VHX-896 and iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Schizophrenia
1 trial
Frequently asked questions
How many neurology & cns Phase I programs exist?
11 programs match both the therapeutic area and stage filters in our published index.